Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | AMRZ | NRG |
|---|---|---|
| Price | $37.18 | $96.50 |
| Change today | ▼ 0.56% | ▲ 0.89% |
| Market cap | $20.33B | $20.29B |
| Return, 3 months | -29.3% | -31.2% |
| Return, year to date | -30.4% | -38.8% |
| Return, 1 year | -22.3% | -39.7% |
| P/E (TTM) | 16.6 | 25.1 |
| P/B | 1.6 | 4.8 |
| P/E percentile vs own 5y | 1st | 77th |
| Dividend yield | – | 1.90% |
| Revenue growth (YoY, latest qtr) | +8.6% | +11.0% |
| Net profit growth (YoY) | +14.4% | +586.5% |
| Gross margin | 25.1% | 18.8% |
| Operating margin | 15.5% | 6.3% |
| Net margin | 10.1% | 2.4% |
| Return on equity | 9.8% | 26.8% |
| Analyst target vs. price | +38.4% | +106.0% |
| Analyst buy share | 36% | 82% |
| RSI (14) | 32 | 31 |
| 30-day volatility | 28.7% | 40.2% |
| Max drawdown, 1 year | -42.8% | -47.7% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
